A higher proportion of patients with SARC-F≥4 used NSAIDs compared with those with lower scores (88.5% vs 45.3%), although this difference did not reach statistical significance (p=0.06).
← all excerpts
Association between SARC-F as a self-report screening tool for sarcopenia and muscle strength, physical performance, daily activity, patient-reported outcomes and body composition in patients with spondyloarthritis.
1
0.0600
0.0600